Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Farah Choulli
Observed name:
F. Choulli
Institutions:
Cadi Ayyad University,
Centre Hospitalier Universitaire Mohammed VI
Observed institutions:
Cadi Ayyad University,
Centre Hospitalier Universitaire Mohammed VI
ORCID:
0000-0002-5789-6288
Observed ORCID:
0000-0002-5789-6288
OpenAlex ID:
A5015046836
Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
2024
·
Farah Choulli
, Hassan Abdelilah Tafenzi
, et al.
·
BMC Cancer
·
17
PDF
Lung cancer in middle and southern Morocco
2023
·
Hassan Abdelilah Tafenzi
, Farah Choulli
, et al.
·
ecancermedicalscience
·
5
PDF
Development of a well-defined tool to predict the overall survival in lung cancer patients: an African based cohort
2023
·
Hassan Abdelilah Tafenzi
, Farah Choulli
, et al.
·
BMC Cancer
·
4
PDF
Real world results of locally advanced and metastatic lung cancer patients treated with platinum doublet chemotherapy in first line: Moroccan cohort
2024
·
Hassan Abdelilah Tafenzi
, Farah Choulli
, et al.
·
Translational Oncology
·
3
Second-line chemotherapy rechallenge in lung cancer patients: a Moroccan real-world study
2025
·
Hassan Abdelilah Tafenzi
, Farah Choulli
, et al.
·
Frontiers in Oncology
·
2
PDF
378P First-line systemic treatment outcomes in a real-world advanced pancreatic cancer cohort
2024
·
H.A. Tafenzi
, Y. Ait Takniouine
, et al.
·
Annals of Oncology
·
1
PDF
293P Evaluating chemotherapy side effects in Moroccan breast cancer patients and introducing an AI mobile health app for remote support: A comprehensive approach
2024
·
F. Choulli
·
ESMO Open
·
1
PDF
Adjuvant (Ad) and neoadjuvant (NAd) strategies in higher risk hormone receptor–positive (HR+)/HER2-negative (HER2−) early breast cancer (EBC): Moroccan real-world outcomes.
2026
·
Hassan Abdelilah Tafenzi
, Youssef AIT Takniouine
, et al.
·
Journal of Clinical Oncology
567eP A clinically driven AI model for optimal treatment sequencing in non-small cell lung cancer (NSCLC): Moroccan cohort
2026
·
H.A. Tafenzi
, Y. Ait Takniouine
, et al.
·
ESMO Open
Combined impact of patients and disease characteristics on survival outcome in early hormone receptor negative patients across SBR grades.
2025
·
Tafenzi Hassan Abdelilah
, Anass Baladi
, et al.
·
Journal of Clinical Oncology
Real-World Outcomes of Combination Anthracycline and Taxane Adjuvant Therapies in Early Triple-Negative Breast Cancer: A Moroccan Retrospective Analysis
2025
·
Hassan Abdelilah Tafenzi
, Farah Choulli
, et al.
·
JCO Global Oncology
417P: Deep neural networks prognosis for lung cancer with non-omics data: African cohort
2025
·
H.A. Tafenzi
, F. Choulli
, et al.
·
Journal of Thoracic Oncology
PDF
Investigating the outcome of vascular emboli in patients with breast cancer.
2024
·
Tafenzi Hassan Abdelilah
, Farah Choulli
, et al.
·
Journal of Clinical Oncology
PDF
P-356 Oesophageal cancer standing in Morocco from diagnosis to treatments
2023
·
H. Abdelilah Tafenzi
, A. Baladi
, et al.
·
Annals of Oncology
PDF
P-366 Development and validation of a predictive tool for oesophageal cancer patients: A Moroccan-based study
2023
·
H. Abdelilah Tafenzi
, A. Baladi
, et al.
·
Annals of Oncology
PDF
214P Development of a nomogram to predict the progression-free survival in lung cancer patients
2023
·
H.A. Tafenzi
, F. Choulli
, et al.
·
Journal of Thoracic Oncology
PDF
Show more works
View as search
Works count:
16
Citation count:
33
H-index:
3
I10-index:
1
Year
Topic
Type